Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Tract | 12 | 2023 | 308 | 2.120 |
Why?
|
Urogenital Abnormalities | 9 | 2023 | 261 | 1.830 |
Why?
|
Nephrosis | 1 | 2021 | 45 | 0.770 |
Why?
|
Nephrotic Syndrome | 6 | 2021 | 389 | 0.740 |
Why?
|
Hernia, Hiatal | 1 | 2021 | 79 | 0.730 |
Why?
|
Vesico-Ureteral Reflux | 6 | 2023 | 427 | 0.640 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 257 | 0.580 |
Why?
|
Microcephaly | 1 | 2021 | 432 | 0.570 |
Why?
|
Receptors, Nicotinic | 1 | 2019 | 497 | 0.550 |
Why?
|
Kidney | 15 | 2023 | 7183 | 0.510 |
Why?
|
Mutation, Missense | 3 | 2021 | 2563 | 0.500 |
Why?
|
Podocytes | 5 | 2021 | 396 | 0.390 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2019 | 2208 | 0.370 |
Why?
|
Pedigree | 7 | 2020 | 4648 | 0.320 |
Why?
|
Mutation | 10 | 2021 | 29784 | 0.320 |
Why?
|
DNA-Binding Proteins | 4 | 2021 | 9647 | 0.310 |
Why?
|
Transcription Factors | 5 | 2021 | 12207 | 0.270 |
Why?
|
Ventricular Remodeling | 1 | 2012 | 1224 | 0.260 |
Why?
|
Heart Diseases | 2 | 2021 | 2790 | 0.250 |
Why?
|
Congenital Abnormalities | 2 | 2020 | 707 | 0.250 |
Why?
|
Durable Medical Equipment | 1 | 2023 | 23 | 0.230 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4251 | 0.230 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2023 | 165 | 0.200 |
Why?
|
Intranuclear Space | 1 | 2021 | 15 | 0.200 |
Why?
|
Amino Acid Substitution | 3 | 2021 | 1792 | 0.190 |
Why?
|
Myocardium | 2 | 2012 | 4776 | 0.180 |
Why?
|
Spinal Dysraphism | 1 | 2022 | 161 | 0.180 |
Why?
|
Tracheoesophageal Fistula | 1 | 2021 | 129 | 0.180 |
Why?
|
Kidney Diseases | 2 | 2021 | 2147 | 0.170 |
Why?
|
Repressor Proteins | 2 | 2021 | 3023 | 0.170 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1655 | 0.170 |
Why?
|
Protein Stability | 1 | 2021 | 557 | 0.170 |
Why?
|
rho GTP-Binding Proteins | 1 | 2020 | 293 | 0.170 |
Why?
|
Collagen Type IV | 1 | 2019 | 140 | 0.160 |
Why?
|
Zinc Fingers | 1 | 2021 | 585 | 0.160 |
Why?
|
Esophageal Atresia | 1 | 2021 | 201 | 0.160 |
Why?
|
Fraser Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 5 | 2021 | 17449 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2915 | 0.160 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 809 | 0.150 |
Why?
|
Eye Abnormalities | 1 | 2020 | 246 | 0.150 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2021 | 359 | 0.150 |
Why?
|
Xenopus laevis | 1 | 2021 | 957 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.140 |
Why?
|
Rhabdomyolysis | 1 | 2017 | 150 | 0.140 |
Why?
|
Exercise | 1 | 2012 | 5615 | 0.140 |
Why?
|
Actins | 2 | 2021 | 2121 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 713 | 0.140 |
Why?
|
Genetic Testing | 2 | 2019 | 3443 | 0.130 |
Why?
|
Microfilament Proteins | 1 | 2020 | 1152 | 0.130 |
Why?
|
Xenopus | 3 | 2020 | 712 | 0.120 |
Why?
|
Tretinoin | 1 | 2017 | 517 | 0.120 |
Why?
|
Drug Resistance | 1 | 2019 | 1608 | 0.110 |
Why?
|
Models, Molecular | 2 | 2021 | 5458 | 0.110 |
Why?
|
Membrane Proteins | 2 | 2020 | 7879 | 0.110 |
Why?
|
Developmental Disabilities | 1 | 2021 | 1456 | 0.100 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2021 | 3617 | 0.100 |
Why?
|
Cell Line | 3 | 2021 | 15999 | 0.100 |
Why?
|
Child, Preschool | 5 | 2021 | 40992 | 0.100 |
Why?
|
Amino Acid Sequence | 2 | 2021 | 13817 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2015 | 592 | 0.100 |
Why?
|
Echocardiography, Doppler | 1 | 2015 | 934 | 0.090 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 103 | 0.090 |
Why?
|
Transposition of Great Vessels | 1 | 2015 | 589 | 0.090 |
Why?
|
Prognosis | 3 | 2019 | 29050 | 0.090 |
Why?
|
Phenotype | 4 | 2021 | 16365 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2848 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2015 | 770 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2019 | 2108 | 0.090 |
Why?
|
Hospitals, Pediatric | 1 | 2019 | 1766 | 0.090 |
Why?
|
Animals | 15 | 2023 | 168788 | 0.090 |
Why?
|
Heterozygote | 3 | 2020 | 2805 | 0.080 |
Why?
|
Humans | 29 | 2023 | 744220 | 0.080 |
Why?
|
Child | 10 | 2023 | 77679 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3598 | 0.080 |
Why?
|
Graft Survival | 1 | 2019 | 3740 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 964 | 0.080 |
Why?
|
Glycolates | 1 | 2008 | 40 | 0.080 |
Why?
|
Mice | 12 | 2023 | 81178 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4465 | 0.080 |
Why?
|
Arabs | 2 | 2021 | 178 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 5021 | 0.070 |
Why?
|
Male | 14 | 2023 | 350027 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3646 | 0.070 |
Why?
|
Exercise Test | 1 | 2015 | 2075 | 0.070 |
Why?
|
Physical Conditioning, Animal | 1 | 2010 | 362 | 0.070 |
Why?
|
Consanguinity | 2 | 2019 | 456 | 0.070 |
Why?
|
Female | 14 | 2023 | 380197 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9311 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10250 | 0.070 |
Why?
|
Graft Rejection | 1 | 2019 | 4399 | 0.070 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.070 |
Why?
|
Genetic Variation | 1 | 2020 | 6546 | 0.060 |
Why?
|
Epilepsy | 1 | 2021 | 3310 | 0.060 |
Why?
|
Alleles | 3 | 2021 | 6938 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2022 | 25618 | 0.060 |
Why?
|
Homozygote | 2 | 2019 | 1786 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 10 | 0.060 |
Why?
|
Homeodomain Proteins | 2 | 2023 | 2422 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 67 | 0.050 |
Why?
|
Age of Onset | 2 | 2019 | 3270 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2023 | 14556 | 0.050 |
Why?
|
Polyethylene Glycols | 1 | 2008 | 1181 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 40559 | 0.050 |
Why?
|
Infant | 2 | 2021 | 35129 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5853 | 0.050 |
Why?
|
Hemizygote | 1 | 2021 | 28 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15525 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39045 | 0.050 |
Why?
|
Genes, X-Linked | 1 | 2021 | 128 | 0.050 |
Why?
|
Adolescent | 5 | 2022 | 85759 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15538 | 0.050 |
Why?
|
Mutant Proteins | 1 | 2023 | 500 | 0.050 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2702 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2019 | 4188 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23337 | 0.050 |
Why?
|
Pseudopodia | 1 | 2020 | 172 | 0.050 |
Why?
|
Receptors, Interleukin | 1 | 2021 | 245 | 0.050 |
Why?
|
Glomerular Basement Membrane | 1 | 2019 | 33 | 0.040 |
Why?
|
Endopeptidases | 1 | 2023 | 772 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2021 | 281 | 0.040 |
Why?
|
Ireland | 1 | 2019 | 161 | 0.040 |
Why?
|
Larva | 1 | 2020 | 519 | 0.040 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2021 | 434 | 0.040 |
Why?
|
Integrins | 1 | 2023 | 846 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 56436 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 2478 | 0.040 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 697 | 0.040 |
Why?
|
Urogenital System | 1 | 2018 | 86 | 0.040 |
Why?
|
Dogs | 1 | 2023 | 3913 | 0.040 |
Why?
|
Kidney Diseases, Cystic | 1 | 2019 | 186 | 0.040 |
Why?
|
Signal Transduction | 2 | 2020 | 23404 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 713 | 0.040 |
Why?
|
Heart | 1 | 2010 | 4465 | 0.040 |
Why?
|
Nanoparticles | 1 | 2008 | 1905 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1919 | 0.030 |
Why?
|
Gender Identity | 1 | 2022 | 688 | 0.030 |
Why?
|
Cytoplasm | 1 | 2020 | 1539 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2020 | 1549 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1364 | 0.030 |
Why?
|
Jews | 1 | 2017 | 385 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2020 | 783 | 0.030 |
Why?
|
Medical History Taking | 1 | 2019 | 783 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 63119 | 0.030 |
Why?
|
Adult | 5 | 2021 | 214035 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 2020 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2018 | 1202 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2170 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2018 | 849 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2018 | 2839 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2018 | 1080 | 0.030 |
Why?
|
Fetus | 1 | 2020 | 1880 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2019 | 77426 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3588 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2726 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18027 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2019 | 1782 | 0.030 |
Why?
|
Exons | 1 | 2018 | 2439 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4201 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3505 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2411 | 0.020 |
Why?
|
Models, Animal | 1 | 2018 | 2171 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1939 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Medicaid | 1 | 2023 | 2736 | 0.020 |
Why?
|
Rats | 2 | 2021 | 24273 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2575 | 0.020 |
Why?
|
Family | 1 | 2020 | 3148 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2593 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9147 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5216 | 0.020 |
Why?
|
Chemistry, Physical | 1 | 2008 | 156 | 0.020 |
Why?
|
Benzeneacetamides | 1 | 2008 | 39 | 0.020 |
Why?
|
Piperidones | 1 | 2008 | 28 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13036 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9392 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 2008 | 518 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2010 | 894 | 0.020 |
Why?
|
Biophysical Phenomena | 1 | 2008 | 327 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3527 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3523 | 0.020 |
Why?
|
Biophysics | 1 | 2008 | 383 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2008 | 406 | 0.020 |
Why?
|
Risk Factors | 1 | 2012 | 72280 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1184 | 0.020 |
Why?
|
Molecular Structure | 1 | 2008 | 1907 | 0.010 |
Why?
|
Endocytosis | 1 | 2008 | 985 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5722 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14726 | 0.010 |
Why?
|
Lactic Acid | 1 | 2008 | 1132 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21752 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13280 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2010 | 1637 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3689 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12244 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3294 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 20945 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2008 | 3557 | 0.010 |
Why?
|
Zebrafish | 1 | 2010 | 2994 | 0.010 |
Why?
|
Aged | 2 | 2023 | 163253 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2008 | 6386 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15070 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2008 | 3760 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53280 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19907 | 0.010 |
Why?
|
United States | 1 | 2023 | 69867 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10480 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19227 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57768 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26413 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40063 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 21824 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12075 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16687 | 0.010 |
Why?
|
Middle Aged | 1 | 2019 | 213367 | 0.000 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_